Qi Cao
Qi Cao
MSD animal health, Biostatistician
Verified email at
Cited by
Cited by
Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D
B Arifin, LR Idrus, ADI van Asselt, FD Purba, DA Perwitasari, JA Thobari, ...
Quality of Life Research 28, 1179-1190, 2019
The impact of patent expiry on drug prices: a systematic literature review
GT Vondeling, Q Cao, MJ Postma, MH Rozenbaum
Applied health economics and health policy 16, 653-660, 2018
Translation, revision, and validation of the diabetes distress scale for Indonesian type 2 diabetic outpatients with various types of complications
BAS Farm, DA Perwitasari, JA Thobari, Q Cao, PFM Krabbe, MJ Postma
Value in health regional issues 12, 63-73, 2017
The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure
RA de Boer, Q Cao, D Postmus, K Damman, AA Voors, T Jaarsma, ...
JACC: Heart Failure 1 (2), 164-169, 2013
Diabetes distress in Indonesian patients with type 2 diabetes: a comparison between primary and tertiary care
B Arifin, ADI van Asselt, D Setiawan, J Atthobari, MJ Postma, Q Cao
BMC health services research 19 (1), 1-11, 2019
Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management
Q Cao, D Postmus, HL Hillege, E Buskens
Value in Health 16 (4), 529-535, 2013
Continuous-time semi-Markov models in health economic decision making: an illustrative example in heart failure disease management
Q Cao, E Buskens, T Feenstra, T Jaarsma, H Hillege, D Postmus
Medical Decision Making 36 (1), 59-71, 2016
Determining equine influenza virus vaccine efficacy—the specific contribution of strain versus other vaccine attributes
S Reemers, D Sonnemans, L Horspool, S van Bommel, Q Cao, ...
Vaccines 8 (3), 501, 2020
Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines
A Wondimu, Q Cao, JC Wilschut, MJ Postma
BMC Public Health 19, 1-10, 2019
Cost-effectiveness of scaling up modern family planning interventions in low-and middle-income countries: an economic modeling analysis in Indonesia and Uganda
N Zakiyah, ADI van Asselt, D Setiawan, Q Cao, F Roijmans, MJ Postma
Applied health economics and health policy 17, 65-76, 2019
The impact of patent expiry on drug prices: insights from the Dutch market
S van der Schans, GT Vondeling, Q Cao, S van der Pol, S Visser, ...
Journal of market access & health policy 9 (1), 1849984, 2021
Efficacy of a novel intradermal Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions
AAC Jacobs, F Harks, R Pauwels, Q Cao, H Holtslag, S Pel, R Segers
Porcine Health Management 6 (1), 1-11, 2020
The temporal order of fluctuations in atopic disease symptoms and attention-deficit/hyperactivity disorder symptoms: a time-series study in ADHD patients
J Van der Schans, Q Cao, EH Bos, GIJG Rours, PJ Hoekstra, E Hak, ...
European Child & Adolescent Psychiatry 29, 137-144, 2020
Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands
J Luttjeboer, D Setiawan, Q Cao, TC Daemen, MJ Postma
Vaccine 34 (50), 6381-6387, 2016
Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)
SJL Riphagen, I. J., Kleefstra, N., Drion, I., Alkhalaf, A., van Diepen, M ...
PLoS ONE 10 (3), e0120477, 2015
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
Q Cao, E Buskens, HL Hillege, T Jaarsma, M Postma, D Postmus
The European Journal of Health Economics 20, 475-482, 2019
Understanding the improvement in full childhood vaccination coverage in Ethiopia using Oaxaca–blinder decomposition analysis
A Wondimu, Q Cao, D Asuman, J Almansa, MJ Postma, M van Hulst
Vaccines 8 (3), 505, 2020
Cost-effectiveness of treatments in children with attention-deficit/hyperactivity disorder: a continuous-time Markov modeling approach
RD Freriks, JO Mierau, J van der Schans, AP Groenman, PJ Hoekstra, ...
MDM policy & practice 4 (2), 2381468319867629, 2019
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands
MS Jacobs, MWJ Van Leent, RG Tieleman, FGA Jansman, Q Cao, ...
Journal of Medical Economics 20 (12), 1231-1236, 2017
Protection against the New Equine Influenza Virus Florida Clade I Outbreak Strain Provided by a Whole Inactivated Virus Vaccine
S Reemers, S van Bommel, Q Cao, D Sutton, S van de Zande
Vaccines 8 (4), 784, 2020
The system can't perform the operation now. Try again later.
Articles 1–20